Mdxhealth GPS
Ended Awarded Last action
- Contract number
- 36C25725N0242
- Awardee
-
Mdxhealth, Inc. UEI LQGYDJJ9K8Q6
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Opportunity
-
- Q301--674-23-3-035-0018 | NEW | CTX MDxHealth GPS Special Notice · 36C25723Q0843 · Posted May 16, 2023
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92618, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$15,965 | |
| Original award | $15,965 |
About this award
Mdxhealth, Inc. received a $15,964.65 firm fixed price contract award from the Department of Veterans Affairs' Veterans Integrated Service Network 17 on June 5, 2025. This BPA call is for Genomic Prostate Score (GPS) testing services, a molecular diagnostic test designed to assess prostate cancer risk and guide personalized treatment decisions for veterans. The contract carries no set-aside designation and represents a delivery order against Mdxhealth's existing $240,000 blanket purchase agreement with VISN 17 for MDXHEALTH GPS services, which extends through June 4, 2028. Services will be performed at Mdxhealth's facility in Irvine, California, with an ultimate completion date of June 6, 2026.
Mdxhealth, Inc. is a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and operates as a prime contractor with the VA across multiple Veterans Integrated Service Networks. The company leverages proprietary genomic and epigenetic testing technologies to deliver advanced cancer screening capabilities to support personalized diagnosis and treatment for veterans across the VA's national healthcare system. This award is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), a General Services Administration vehicle that streamlines procurement of specialized laboratory diagnostic services for the federal government.
Quick answers
Who was awarded contract 36C25725N0242?
36C25725N0242 was awarded to Mdxhealth, Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on June 5, 2025.
How much is contract 36C25725N0242 worth?
The government has obligated $0 on 36C25725N0242.
Is contract 36C25725N0242 an order under another contract?
Yes. 36C25725N0242 is a BPA call under V797D70066-36C25723A0027, a blanket purchase agreement, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C25725N0242 competed?
The extent of competition for 36C25725N0242 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award